文献

J-GLOBAL ID：201802287127485465   整理番号：18A1014143

日本人1型および2型糖尿病患者におけるインスリングラルギン100U/mLから同用量のグラルギン300U/mlへの切り替えの有効性と安全性:後ろ向き分析

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis

著者 (19件)： Nakanishi Shuhei (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Iwamoto Masahiro (Iwamoto Medical Clinic, Japan) ,  Kamei Shinji (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Hirukawa Hidenori (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Shimoda Masashi (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Tatsumi Fuminori (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kohara Kenji (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Obata Atsushi (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kimura Tomohiko (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kinoshita Tomoe (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Irie Shintaro (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Sanada Junpei (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Fushimi Yoshiro (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Nishioka Momoyo (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Mizoguchi Akiko (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kameyama Miyuki (Iwamoto Medical Clinic, Japan) ,  Mune Tomoatsu (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kaku Kohei (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan) ,  Kaneto Hideaki (Division of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 57  号： 10  ページ： 1381-1389(J-STAGE)  発行年： 2018年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ・目的:インスリングラルギン[300U/mL(Gla-300...

シソーラス用語： ヒト ,...
準シソーラス用語： インスリングラルギン ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1014143&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (4件)： グラルギン100U/ML ,  グラルギン300U/ML ,  日本人糖尿病患者 ,  外来診療所

分類 (2件)： 代謝異常・栄養性疾患の治療  (GD05030F) ,  糖質代謝作用薬の臨床への応用  (GW13030B)

引用文献 (18件)：

• 1. International Diabetes Federation. Diabetes Atlas 7th edition [Internet]. 2015 [cited 2017 Jan. 20]. Available from: http://www.diabetesatlas.org
• 2. The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367: 319-328, 2012.
• 3. Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26: 3080-3086, 2003.
• 4. Bretzel RG, Nuber U, Landgraf W, et al. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. Lancet 371: 1073-1084, 2008.
• 5. Davies M, Lavalle-Gonzalez F, Storms F, et al. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes Obes Metab 10: 387-399, 2008.

タイトルに関連する用語 (11件)： 日本人 ,  2型糖尿病 ,  患者 ,  インスリングラルギン ,  ML ,  用量 ,  グラルギン ,  切り替え ,  有効性 ,  安全性 ,  後ろ向き分析